(2) an in-depth knowledge of all State medicinal 
marijuana programs and the ability to tailor the sur-
veys under subsection (a) accordingly. 
(c) CONDUCT OF SURVEYS.—The surveys conducted 
under subsection (a) shall meet the following criteria: 
(1) One survey shall collect information from 
veterans who use cannabis, including both veterans 
enrolled in the health care system established under 
section 1705(a) of title 38, United States Code, and 
veterans who are not so enrolled. 
(2) One survey shall collect information from 
health care providers of the Department of Veterans 
Affairs. 
(3) Each survey shall be conducted in a manner 
that ensures the anonymity of the individual being 
surveyed. 
(d) MATTERS SURVEYED.— 
(1) VETERANS.—The survey described in sub-
section (c)(1) shall cover the following subjects: 
(A) The current medicinal cannabis use by 
the veteran, or the intent or desire by the vet-
eran to use medicinal cannabis, and the reasons 
for such use, intent, or desire. 
(B) The conditions, symptoms, or both, 
that the veteran uses cannabis to treat. 
VerDate Sep 11 2014 
06:21 Apr 07, 2022
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6991.IH
H6991
pbinns on DSKJLVW7X2PROD with BILLS
(C) The types of cannabis and cannabis 
products used by the veteran, including with re-
spect to— 
(i) tetrahydrocannabinol or cannabidi-
ol content; 
(ii) indica, sativa, mixes, or hybrids; 
and 
(iii) flower, oils, hash or kief, con-
centrates (wax, shatter, budder), edibles, 
drinks, tinctures, and topical ointments. 
(D) Other medications taken by the vet-
eran concurrently with cannabis and any medi-
cations the veteran stopped using because of 
the use of cannabis. 
(E) How the veteran is self-administering 
medicinal cannabis, including— 
(i) the method; 
(ii) the typical times each day the vet-
eran self-administers; 
(iii) the frequency of different prod-
ucts per day and for what condition, symp-
tom, or both; and 
(iv) the amounts per product. 
VerDate Sep 11 2014 
06:21 Apr 07, 2022
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6991.IH
H6991
pbinns on DSKJLVW7X2PROD with BILLS
(F) The ratings and descriptions of the ef-
fectiveness of using cannabis to treat condi-
tions, symptoms, or both. 
(G) Any experiences with side effects. 
(H) The number of different cannabis 
products tried before settling on the current 
product. 
(I) The typical source of medical cannabis 
(such 
as 
a 
single 
dispensary, 
multiple 
dispensaries, mail order, or other source), the 
typical purchase frequency, and the typical 
amount purchased. 
(J) The sources of information the veteran 
uses for products and dosages. 
(K) Factors that influence the choice of 
the veteran for using a chosen product (such as 
with respect to the levels of tetrahydrocannabi-
nol or cannabidiol content, cost, availability, 
consistency, or strain). 
(L) Any other matters determined appro-
priate. 
(2) HEALTH CARE PROVIDERS.—The survey de-
scribed in subsection (c)(2) shall cover the following 
subjects: 
VerDate Sep 11 2014 
06:21 Apr 07, 2022
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6991.IH
H6991
pbinns on DSKJLVW7X2PROD with BILLS
(A) A description of the experience of the 
health care provider with respect to patents 
using medicinal cannabis. 
(B) A description by the health care pro-
vider of how medicinal cannabis is changing pa-
tients. 
(C) A description of how treatment plans 
have been modified after a veteran discloses 
using cannabis. 
(D) Any documentation of the products, 
dosages, or frequency of such cannabis use in 
the medical records of the veteran. 
(E) Reporting of adverse events. 
(F) The sources of information used by the 
health care provider with respect to cannabis 
products and the medical effectiveness of can-
nabis. 
(G) Any other matters determined appro-
priate. 
(e) REPORT.—Not later than one year after the date 
of the enactment of this Act, the Secretary shall submit 
to the Committees on Veterans’ Affairs of the Senate and 
House of Representatives a report on the results of the 
surveys conducted under this section. 
VerDate Sep 11 2014 
06:21 Apr 07, 2022
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6991.IH
H6991
pbinns on DSKJLVW7X2PROD with BILLS